Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $19.54 | $64.62 |
| Change | 0.09 (0.46%) | -0.92 (-1.40%) |
| Market Cap | $2.47B | $12.45B |
| Trailing P/E | 54.28 | 0.00 |
| Forward P/E | -23.26 | -21.12 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $35.72 | $69.48 |
| 52-Week Low | $16.10 | $22.47 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $0.36 | $-4.21 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -30.56% | -35.70% | -36.50% | -59.16% | 39.27% | 39.27% |
| BBIO | 21.37% | 80.30% | 175.92% | 39.15% | 134.56% | 134.56% |